Showing results (351-360 of 450) with videos related to

Sort By:
Pageof 45
Cancer Research|April 5, 2012
Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regressionXiaoyan Liang, Michael E De Vera, William J Buchser, et al.
Cell Research|April 5, 2017
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancerRui Kang, Yangchun Xie, Qiuhong Zhang, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 16, 2020
Long-Term Surgical Complications After Pancreatoduodenectomy: Incidence, Outcomes, and Risk FactorsJames A Brown, Mazen S Zenati, Richard L Simmons, et al.
Annals of Surgical Oncology|December 11, 2013
Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysisDeepa Magge, Mazen S Zenati, Frances Austin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 18, 2014
Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor gradeJon M Davison, Haroon A Choudry, James F Pingpank, et al.
Cancer Gene Therapy|December 18, 2007
Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase geneS Chalikonda, M H Kivlen, M E O'Malley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline UpdateAlok A Khorana, Pamela B Mangu, Jordan Berlin, et al.
Surgical Endoscopy|August 5, 2024
Impact of team performance on the surgical safety checklist on patient outcomes: an operating room black box analysisAmr I Al Abbas, Jennie Meier, William Daniel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice GuidelineAlok A Khorana, Pamela B Mangu, Jordan Berlin, et al.
Developmental Cell|August 14, 2018
PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated ImmunometabolismChangfeng Li, Ying Zhang, Xing Cheng, et al.
Pageof 45